KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364 | -100.0% | 272 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $6,771,484 | +35539.4% | 1,991,613 | +56803.2% | 0.02% | – |
| Q3 2022 | $19,000 | -99.6% | 3,500 | -99.0% | 0.00% | -100.0% |
| Q3 2020 | $5,106,000 | -67.2% | 349,723 | -86.5% | 0.03% | -67.9% |
| Q2 2019 | $15,552,000 | +7.7% | 2,596,323 | +68.4% | 0.08% | +14.1% |
| Q4 2018 | $14,446,000 | -10.8% | 1,541,718 | +62.2% | 0.07% | +6.0% |
| Q3 2018 | $16,187,000 | -33.9% | 950,493 | -34.1% | 0.07% | -31.6% |
| Q2 2018 | $24,503,000 | -6.8% | 1,442,183 | -26.4% | 0.10% | -10.9% |
| Q1 2018 | $26,283,000 | -18.3% | 1,958,527 | -41.6% | 0.11% | -20.9% |
| Q4 2017 | $32,179,000 | +2236.9% | 3,351,996 | +8407.6% | 0.14% | +1290.0% |
| Q3 2014 | $1,377,000 | +270.2% | 39,400 | +392.5% | 0.01% | +400.0% |
| Q2 2014 | $372,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |